We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Conor Medsystems, Inc., a developer of innovative, controlled vascular drug delivery technologies, announced that the company has received regulatory approval for extending the shelf life of Conor's CoStar cobalt chromium paclitaxel-eluting stent in the European Union to twelve months from the current shelf life of six months.
Inviro Medical Devices has entered into an exclusive, long-term agreement with SafePro USA and its parent company, Formosa Medical Devices, to sell, market and distribute SafePro safety syringes in the U.S. and Canada.
Johnson & Johnson has filed an application with the Commerce Commission regarding its global acquisition of the consumer healthcare division of Pfizer Inc.
The National Cancer Institute has awarded a three-year Small Business Innovation Research Phase II Competitive Renewal grant of up to $3 million to Artann Laboratories, according to the firm's development partner, vision and sensing technology firm ProUroCare Medical.
A Chicago chip manufacturer is mulling a full-scale move to Arizona as commerce groups and industry advocates try to sway the company from the Windy City.
Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc., announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System.